Dulaglutide, 923950-08-7

Laƙabiulaglutide - bayani a cikin PBS / dulaglutide

Lambar CAS: 923950-08-7

Kamfanin Lamba: GT-F002

Jerin: H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Glu-Gln-Ala-Ala-Lys-Glu-Phe-Ile- Ala-Trp-Leu-Val-Lys-Gly-Gl y-Gly-OH

Tsarin kwayoyin halitta: C149H221N37O49

Nauyin Kwayoyin: 3314.62

Dulaglutide CAS NO.923950-08-7.jpg

Alamun fasaha:

Bayyanar Farin foda
Tsabta (HPLC) ya kasance ≥95.0%

Heterozygosity guda ɗaya ya kasance ƙasa da 2.0%

Acetic acid abun ciki ya kasance daga 5.0% zuwa 12.0%

Abubuwan da ke cikin danshi ya kasance ≤10.0%

Abubuwan da ke cikin peptide sun kasance ≥80.0%

Shiryawa da jigilar kaya:

Ƙananan zafin jiki, tattarawar injin, daidai zuwa milligram bisa buƙata.

Bayanin samfur:

Durraglutide sabon GLP-1R agonist ne na dogon lokaci, wanda aka samo shi daga hadewar DPP-4 inhibitory GLP-1 analogues da nau'in nau'in immunoglobulin na ɗan adam IgG4-Fc.Ayyukansa yayi kama da na GLP-1 na endogenous a cikin bayyanar asibiti, tare da rabin rayuwa na kwanaki 5, kuma yana iya jinkirta cirewar koda yadda ya kamata.FDA ta amince da dulaglutide don allurar subcutaneous a cikin Satumba 2014. Hukumar Tarayyar Turai ta amince da dulaglutide don allurar subcutaneous a Turai a cikin Disamba 2014.

Adana: Daskare bushe a -20 ℃ kuma adana shi daga haske

Bayani: Don dalilai na bincike kawai, ba don batutuwan ɗan adam ba